Screener
Nuvation Bio NUVB EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
FAQ
- What is Nuvation Bio's EPS (diluted)?
- Nuvation Bio (NUVB) reported EPS (diluted) of -$0.18 in Q2 2026.
- How has Nuvation Bio's EPS (diluted) changed year-over-year?
- Nuvation Bio's EPS (diluted) decreased by 5.9% year-over-year, from -$0.17 to -$0.18.
- What is the long-term trend for Nuvation Bio's EPS (diluted)?
- Over 4 years (2021 to 2025), Nuvation Bio's EPS (diluted) has grown at a 8.1% compound annual growth rate (CAGR), from -$0.44 to -$0.60.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Nuvation Bio's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude